Vaishali Pharma Q1 Results Revenue ₹1,807.98 Million Net Profit ₹169.90 Million

Vaishali Pharma's Q1 results for the fiscal year 2024 show a mixed performance. The company's revenue from operations was ₹1,807.98 lakhs, which is a significant decrease compared to the previous quarter's revenue of ₹3,239.60 lakhs. This drop in revenue indicates that the company faced challenges in generating sales during this quarter. 

Vaishali Pharma managed to achieve a net profit of ₹169.90 lakhs in Q1 FY2024. This is a notable improvement from the previous quarter, where the company reported a net loss of ₹468.25 lakhs. The company's profitability was supported by better cost management and a reduction in expenses. The total income for the quarter was ₹1,850.43 lakhs, which includes other income of ₹42.45 lakhs. 

Vaishali Pharma's expenses were well-controlled, with total expenditure amounting to ₹1,583.41 lakhs. This helped the company to report a profit before tax of ₹227.02 lakhs, a positive change from the previous quarter's loss.

Vaishali Pharma faced a decline in revenue, its ability to turn a profit shows that the company is improving its financial health, focusing on better cost control, and striving to overcome the challenges it faced earlier.

Source: Here 

For More Q1 Results check our Twitter Page 

Vaishali Pharma Q1 Results 2024-2025 

Vaishali Pharma's Q1 results for the financial year 2024-2025 provide an in-depth look at how the company performed during the first quarter. The company generated substantial revenue from its operations, totaling ₹1,807.98 million, which is a positive sign of steady demand for its products. 

Here's the information:

These results highlight Vaishali Pharma's resilience and strategic management in navigating the challenges of the pharmaceutical industry.

Vaishali Pharma

The table shows key financial details for Vaishali Pharma. The Market Cap is ₹177 crore, which is the total value of all its shares combined. The Current Price of the stock is ₹166, meaning that's how much one share costs right now. 

Here's the financial data presented in a table format:

This table summarizes the key financial metrics of the company. Let me know if you need any further details!

Quarterly Results 

Vaishali Pharma had sales of ₹27.90 crores and expenses of ₹24.95 crores, leading to an operating profit of ₹2.95 crores and an operating profit margin of 10.57%. They earned ₹0.47 crores from other income. 

Here's information of Vaishali Pharma's financial performance over three periods:

About Vaishali Pharma

Vaishali Pharma was founded in 1989 and has grown into a major player in the pharmaceutical industry. The company started with a clear vision and a strong desire to succeed. Over the years, it has evolved and expanded its operations both in India and internationally. Vaishali Pharma is known for its commitment to high-quality products, which is supported by its ISO 9001:2008 certification for Quality Management. This certification, awarded by BM Trada UKAS, confirms that their products meet stringent quality standards.

Vaishali Pharma is dedicated to producing pharmaceutical and healthcare products that are reliable and effective. It has a wide range of over 250 formulation brands that are marketed in various countries around the world. These products are made in facilities that hold prestigious accreditations like WHO-GMP, EU-GMP, and USFDA, ensuring they meet global standards for quality and safety.

Vaishali Pharma's success is also due to its state-of-the-art infrastructure and a team of skilled professionals. The company is always adapting to meet the evolving needs of the market, making it one of the fastest-growing organizations in the industry. With its headquarters in Mumbai, India, and offices in Vietnam, as well as joint ventures in D.R. Congo, Kenya, and Russia, Vaishali Pharma is expanding its reach globally.